Advice from world-class founders and operators

Culture, in practice, is the bar you hold and what you tolerate when people miss it. You set the bar in the first conversation with hire number one and it’s reinforced (or quietly eroded) every week after that.

What has changed most visibly in the past two years is the appetite from investors, health systems, and policymakers to close the gap between European innovation and real-world deployment at scale.

There's a huge population of people with chronic, severe paralysis who are desperate for something that actually works for them, and nobody is really building for them. That's where we wanted to go.

What would it mean for ordinary people to have a meaningful stake in their own energy supply?

Heart disease remains the largest driver of healthcare expenditure worldwide, yet it is also one of the most manageable conditions when detected early.

Venga is building the platform layer for modern hosting, a vertically integrated toolset that allows anyone to create, manage and monetise gatherings with ease.

The fastest-growing companies in the current market are converging on a different approach. Hire for intrinsic drive, adaptability, and raw capability.

Learn more about our latest Venture Studio spinout, and how they’re transforming the insurance landscape

AI is increasingly the tool that exposes those inefficiencies and removes them at scale, a practical decision-making engine embedded directly into real-world systems. 

Nebuly is building the visibility layer for the AI era, a new class of analytics that helps enterprises truly understand how people use generative AI.

Looking back, the single most important decision we made was starting B2C first, even though it meant slower growth.

Europe invented modern mining and then forgot how to do. But there's still an opportunity to take ownership of how its critical materials are accessed and processed, and to extend its innovations to the rest of the world.

If we want to meaningfully improve outcomes for neurodegenerative conditions, we need to shift our focus. Not just toward better treatments, but toward better lives after diagnosis.

The defence industry is an increasingly critical market and commercial testing ground for the next generation of maritime technologies seeking validation, real-world application, and pathways to scale.